Filing Details
- Accession Number:
- 0000899243-19-008806
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-03-22 16:30:22
- Reporting Period:
- 2019-03-22
- Accepted Time:
- 2019-03-22 16:30:22
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1401708 | Nanostring Technologies Inc | NSTG | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1070844 | A Stephen Schwarzman | C/O The Blackstone Group L.p. 345 Park Avenue New York NY 10154 | No | No | Yes | No | |
1393818 | L.p. Group Blackstone | 345 Park Avenue New York NY 10154 | No | No | Yes | No | |
1404071 | L.l.c. Management Group Blackstone | C/O The Blackstone Group L.p. 345 Park Avenue New York NY 10154 | No | No | Yes | No | |
1431439 | Clarus Ventures Ii Gp, L.p. | C/O Clarus Ventures 101 Main Street, Suite 1210 Cambridge MA 02142 | No | No | Yes | No | |
1431443 | Clarus Lifesciences Ii, L.p. | C/O Clarus Ventures, 101 Main Street, Suite 1210 Cambridge MA 02142 | No | No | Yes | No | |
1464695 | Blackstone Holdings I/Ii Gp Inc | C/O The Blackstone Group L.p. 345 Park Avenue New York NY 10154 | No | No | Yes | No | |
1484870 | L.p. Ii Holdings Blackstone | C/O The Blackstone Group L.p. 345 Park Avenue New York NY 10154 | No | No | Yes | No | |
1762201 | L.l.c. Ii Clarus Blackstone | C/O The Blackstone Group L.p. 345 Park Avenue New York NY 10154 | No | No | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2019-03-22 | 2,000,000 | $21.62 | 2,036,025 | No | 4 | S | Indirect | See Footnotes |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Indirect | See Footnotes |
Footnotes
- This amount represents the $23.00 public offering price per share of common stock, par value $0.0001 per share, of NanoString Technologies, Inc. (the "Issuer"), less the underwriting discount of $1.38 per share.
- These securities are held directly by Clarus Lifesciences II, L.P. ("Clarus II"). Clarus Ventures II GP, L.P. ("Clarus II GP") is the sole general partner of Clarus II. Blackstone Clarus II L.L.C. is the sole general partner of Clarus GP. The sole member of Blackstone Clarus II L.L.C. is Blackstone Holdings II L.P. The sole general partner of Blackstone Holdings II L.P. is Blackstone Holdings I/II GP Inc. The controlling shareholder of Blackstone Holdings I/II GP Inc. is The Blackstone Group L.P. The sole general partner of The Blackstone Group L.P. is Blackstone Group Management L.L.C. Blackstone Group Management L.L.C. is wholly-owned by Blackstone's senior managing directors and controlled by its founder, Stephen A. Schwarzman.
- Information with respect to each of the Reporting Persons is given solely by such Reporting Person, and no Reporting Person has responsibility for the accuracy or completeness of information supplied by another Reporting Person.
- Each of the Reporting Persons (other than Clarus II) disclaims beneficial ownership of the securities held by Clarus II, except to the extent of such Reporting Person's pecuniary interest therein, and, pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, each of the Reporting Persons (other than Clarus II) states that the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of all of the reported securities for purposes of Section 16 or for any other purpose.